Nicolas Lepareur
Lepareur, Nicolas, 1977-....
VIAF ID: 197072696 (Personal)
Permalink: http://viaf.org/viaf/197072696
Preferred Forms
- 100 1 _ ‡a Lepareur, Nicolas, ‡d 1977-....
- 100 0 _ ‡a Nicolas Lepareur
4xx's: Alternate Name Forms (2)
Works
Title | Sources |
---|---|
(188)Re-SSS/Lipiodol: Development of a Potential Treatment for HCC from Bench to Bedside. | |
188Re-loaded lipid nanocapsules as a promising radiopharmaceutical carrier for internal radiotherapy of malignant gliomas | |
18th European Symposium on Radiopharmacy and Radiopharmaceuticals | |
68Ga and 188Re Starch-Based Microparticles as Theranostic Tool for the Hepatocellular Carcinoma: Radiolabeling and Preliminary In Vivo Rat Studies | |
Automation of labelling of Lipiodol with high-activity generator-produced 188Re | |
Cell Uptake and Biocompatibility of Nanoparticles Prepared from Poly(benzyl malate) (Co)polymers Obtained through Chemical and Enzymatic Polymerization in Human HepaRG Cells and Primary Macrophages. | |
Characterization of the distribution, retention, and efficacy of internal radiation of 188Re-lipid nanocapsules in an immunocompromised human glioblastoma model | |
Chelated hydrazido(3-)rhenium(V) complexes: on the way to the nitrido-M(V) core (M = Tc, Re). | |
Development of 99mTc labelled Lipiodol: biodistribution following injection into the hepatic artery of the healthy pig | |
Development of Biocompatible and Functional Polymeric Nanoparticles for Site-Specific Delivery of Radionuclides. | |
Effect of Stabilized Iodized Oil Emulsion on Experimentally Induced Hepatocellular Carcinoma in Rats | |
Gemcitabine and Oxaliplatin, but Not Sorafenib or Paclitaxel, Have a Synergistic Effect with Yttrium-90 in Reducing Hepatocellular Carcinoma and Cholangiocarcinoma Cell Line Viability | |
Hepatocellular carcinoma metastasis targeting with somatostatin analogue radiolabelled with rheniu m-188. | |
In vitro demonstration of synergy/additivity between (188)rhenium and sorafenib on hepatoma lines: preliminary results. | |
Increased Lipiodol uptake in hepatocellular carcinoma possibly due to increased membrane fluidity by dexamethasone and tamoxifen. | |
Lipid nanocapsules loaded with rhenium-188 reduce tumor progression in a rat hepatocellular carcinoma model | |
Locoregional Confinement and Major Clinical Benefit of 188Re-Loaded CXCR4-Targeted Nanocarriers in an Orthotopic Human to Mouse Model of Glioblastoma. | |
Main applications of hybrid PET-MRI contrast agents: a review. | |
Mixed-ligand complexes of yttrium-90 dialkyldithiocarbamates with 1,10-phenanthroline as a possible agent for therapy of hepatocellular carcinoma | |
Occupational radiation exposure of medical staff performing ⁹⁰Y-loaded microsphere radioembolization. | |
Overview of Radiolabeled Somatostatin Analogs for Cancer Imaging and Therapy | |
Preliminary results of the Phase 1 Lip-Re I clinical trial: biodistribution and dosimetry assessments in hepatocellular carcinoma patients treated with 188Re-SSS Lipiodol radioembolization | |
Pyclen Tri-n-butylphosphonate Ester as Potential Chelator for Targeted Radiotherapy: From Yttrium(III) Complexation to (90)Y Radiolabeling. | |
Reduction of β-radiation exposure during preparation of 188Re-labelled Lipiodol for hepatocellular carcinoma treatment | |
Rhenium-188 Labeled Radiopharmaceuticals: Current Clinical Applications in Oncology and Promising Perspectives. | |
The role of the capping bond effect on pyclen natY3+/90Y3+ chelates: full control of the regiospecific N-functionalization makes the difference | |
Stable and Inert Yttrium(III) Complexes with Pyclen-Based Ligands Bearing Pendant Picolinate Arms: Toward New Pharmaceuticals for β-Radiotherapy | |
Study of Binding Kinetics and Specificity of 99mTc-SSS-Complex and 99mTc-HMPAO to Blood Cells. | |
Syntheses and reactivity of 'sulfur rich' Re(iii) and Tc(iii) complexes containing trithioperoxybenzoate, dithiobenzoate and dithiocarbamate ligands. | |
Transarterial Radioembolization (TARE) Agents beyond Y-Microspheres | |
Tumor eradication in rat glioma and bypass of immunosuppressive barriers using internal radiation with (188)Re-lipid nanocapsules | |
Vectorisation ciblée de radionucléides via les peptides GBVA10-9 et CPB pour le diagnostic et/ou la thérapie du carcinome hépatocellulaire | |
Vectorisations active et passive de radiopharmaceutiques du technetium-99m et du rhénium-188 pour l'imagerie médicale et la thérapie |